MiRNA signature associated with outcome of gastric cancer patients following chemotherapy

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Kim, Chang ^a   Kim, Hark K ^b,c   Rettig, R Luke ^a   Kim, Joseph ^b   Lee, Eunbyul T ^b   Aprelikova, Olga ^b   Choi, Il J ^c   Munroe, David J ^a   Green, Jeffrey E ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; FLUOROURACIL; LET7G; MICRORNA; MICRORNA 1; MICRORNA 16; MICRORNA 181; MICRORNA 34; MICRORNA 342; RNA; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RESISTANCE; CANCER SURVIVAL; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG RESPONSE; ENDOSCOPIC BIOPSY; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RNA ANALYSIS; STOMACH ADENOCARCINOMA; DISEASE COURSE; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION PROFILING; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; STOMACH; STOMACH TUMOR; TREATMENT OUTCOME;

ADULT; CISPLATIN; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; STOMACH; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 81555234231     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-79     Document Type: Article

References (25)

1. MicroRNAs: genomics, biogenesis, mechanism, and function. Bartel DP, Cell 2004 116 2 281 297 10.1016/S0092-8674(04)00045-5 14744438 (Pubitemid 38167318)
2. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR, Israel MA, Cancer Res 2007 67 6 2456 2468 10.1158/0008-5472.CAN-06-2698 17363563 (Pubitemid 46548930)
3. MicroRNAs in Cancer. Garzon R, Calin GA, Croce CM, Annu Rev Med 2009 60 167 179 10.1146/annurev.med.59.053006.104707 19630570
4. Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. Nakajima G, Hayashi K, Xi Y, Kudo K, Uchida K, Takasaki K, Yamamoto M, Ju J, Cancer Genomics Proteomics 2006 3 5 317 324 18172508 (Pubitemid 44701551)
5. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, Liang S, Leminen A, Deng S, Smith L, Johnstone CN, Chen XM, Liu CG, Huang Q, Katsaros D, Calin GA, Weber BL, Butzow R, Croce CM, Coukos G, Zhang L, Cancer Res 2008 68 24 10307 10314 10.1158/0008-5472.CAN-08-1954 19074899
6. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y, J Gastroenterol Hepatol 2009 24 4 652 657 10.1111/j.1440-1746.2008. 05666.x 19175831
7. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y, Kaminishi M, Calin GA, Croce CM, Lancet Oncol 11 2 136 146
8. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, Wang B, Suster S, Jacob ST, Ghoshal K, J Biol Chem 2008 283 48 33394 33405 10.1074/jbc.M804788200 18818206
9. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, Huang D, Chen X, Zhang H, Zhuang R, Deng T, Liu H, Yin J, Wang S, Zen K, Ba Y, Zhang CY, Eur J Cancer 2011 47 5 784 791 10.1016/j.ejca.2010.10.025 21112772
10. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T, Cancer Res 2004 64 11 3753 3756 10.1158/0008-5472.CAN-04-0637 15172979 (Pubitemid 38697282)
11. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Oh HK, Tan AL, Das K, Ooi CH, Deng NT, Tan IB, Beillard E, Lee J, Ramnarayanan K, Rha SY, Palanisamy N, Voorhoeve PM, Tan P, Clin Cancer Res 2011 17 9 2657 2667 10.1158/1078-0432.CCR-10-3152 21415212
12. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity. Salerno E, Scaglione BJ, Coffman FD, Brown BD, Baccarini A, Fernandes H, Marti G, Raveche ES, Mol Cancer Ther 2009 8 9 2684 2692 10.1158/1535-7163.MCT-09-0127 19723889
13. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, Hong L, Liu J, Fan D, Int J Cancer 2008 123 2 372 379 10.1002/ijc.23501 18449891 (Pubitemid 351842022)
14. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. Shimizu S, Takehara T, Hikita H, Kodama T, Miyagi T, Hosui A, Tatsumi T, Ishida H, Noda T, Nagano H, Doki Y, Mori M, Hayashi N, J Hepatol 52 5 698 704
15. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z, You Y, Brain Res 2008 1236 185 193 18710654
16. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD, Washington MK, Paraskeva C, Willson JK, Kaz AM, Kroh EM, Allen A, Fritz BR, Markowitz SD, Tewari M, Oncogene 2008 27 27 3880 3888 10.1038/onc.2008.10 18264139 (Pubitemid 351862055)
17. The miR-34 family in cancer and apoptosis. Hermeking H, Cell Death Differ 17 2 193 199
18. Tumour stem cells and drug resistance. Dean M, Fojo T, Bates S, Nat Rev Cancer 2005 5 4 275 284 10.1038/nrc1590 15803154 (Pubitemid 40488633)
19. A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer. Balko JM, Black EP, BMC Cancer 2009 9 145 10.1186/1471-2407-9-145 19439077
20. Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy. Kim HK, Choi IJ, Kim CG, Kim HS, Oshima A, Yamada Y, Arao T, Nishio K, Michalowski A, Green JE, Pharmacogenomics J 2010
21. Japanese classification of gastric carcinoma - 2nd English edition - response assessment of chemotherapy and radiotherapy for gastric carcinoma: clinical criteria. Gastric Cancer 2001 4 1 1 8 10.1007/s101200100009 11706621 (Pubitemid 32625928)
22. DNA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer. Kim HK, Choi IJ, Kim HS, Kim JH, Kim E, Park IS, Chun JH, Kim IH, Kim IJ, Kang HC, Park JH, Bae JM, Lee JS, Park JG, Biochem Biophys Res Commun 2004 316 3 781 789 10.1016/j.bbrc.2004.02.109 15033468 (Pubitemid 38372162)
23. Analysis of gene expression data using BRB-ArrayTools. Simon R, Lam A, Li MC, Ngan M, Menenzes S, Zhao Y, Cancer Inform 2007 3 11 17 19455231 (Pubitemid 47075796)
24. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J, Eur J Cancer 2009 45 2 228 247 10.1016/j.ejca.2008.10.026 19097774
25. Semi-supervised methods to predict patient survival from gene expression data. Bair E, Tibshirani R, PLoS Biol 2004 2 4 108 10.1371/journal.pbio.0020108 15094809 (Pubitemid 39234509)